Medicine & Life Sciences
Insulins
100%
Biosimilar Pharmaceuticals
96%
Systematic Reviews
51%
Safety
40%
Insulin
33%
Pharmacokinetics
29%
Insulin Glargine
27%
MK-1293
23%
SAR342434
22%
fluchloralin
22%
Insulin Lispro
15%
Latin America
11%
Controlled Clinical Trials
10%
United States Food and Drug Administration
9%
Information Storage and Retrieval
9%
Sample Size
8%
PubMed
7%
Research Personnel
6%
Clinical Studies
6%
Randomized Controlled Trials
6%
Healthy Volunteers
6%
Health Care Outcome Assessment
6%
Databases
5%
Health
4%
Agriculture & Biology
systematic review
90%
insulin
60%
pharmacodynamics
59%
pharmacokinetics
45%
immunogenicity
27%
clinical trials
24%
Latin America
13%
synthesis
12%
volunteers
10%
researchers
9%
sampling
4%
Chemical Compounds
Insulin Derivative
71%
Safety
59%
Pharmacokinetics
34%